Table 2.

Summary of clinical status and kidney function before and after treatment.

Patient no.	PET-CT, moa	PET-CT: clinical status	Pretreatment creatinine, mg/dLb	Posttreatment creatinine, mg/dLb	Posttreatment creatinine, moa
1	3	No residual disease	0.67	0.56	17
2	4	Overall decreased uptake in anorectal region; some residual uptake	2.16	2.27	0
3	N/A	3-mo follow-up pending	1.69	1.18	0
4	27	No residual disease	3–4.5c	3–4.5d	28

Abbreviations: PET-CT, positron emission tomography–computed tomography; N/A, not available.

^aMonths after treatment completion.

^bTo convert to micromoles per liter, multiply by 88.4.

^cBaseline listed. Pretreatment creatinine range (6 months): 2.13 to 4.28 mg/dL.^b

^dBaseline listed. Posttreatment creatinine range 2.76 to 5.3 mg/dL.^b Most recent creatinine level, 2.76 mg/dL.^b